News | Radiation Therapy | February 03, 2016

Radioactive Medicine Markets Poised for Double-digit Growth

Nuclear medicine, proton therapy and brachytherapy expected to grow more than twice as fast as total global health expenditures to 2030

MEDraysintell, nuclear medicine, proton therapy, brachytherapy, global markets, 2030

February 3, 2016 — The nuclear medicine, proton therapy and brachytherapy markets represent less than 0.1 percent of global health expenditures but are expected to grow more than twice as fast, according to a new report from MEDraysintell.

Global health expenditures reached some $7.4 billion in 2014 and should grow by 3-4 percent per year to 2030. The nuclear medicine, proton therapy and brachytherapy markets reached about $5.8 billion in 2014 and are expected to grow by 10-11 percent annually to 2030. There is an increasing interest from investors and industry as new technologies and products are being marketed or under development.

The global nuclear medicine market is expected to reach $24 billion by 2030, showing an annual average growth of 11 percent, with radiotherapeutics being key drivers of this growth. The number of operational medical cyclotrons is also expected to grow with the emergence of the Asian and South American markets and the need of tools for new proprietary tracers.

The global proton therapy market saw record sales orders at just over $1 billion in 2015, more than twice as much as in 2014.

The global market for brachytherapy is expected to grow by 8 percent a year to 2030, mainly driven by microspheres and electronic brachytherapy and with the low-dose rate (LDR) brachytherapy seeds market mainly growing in emerging regions.

For more information:

Related Content

Penn Medicine Treats World's First Patient on Varian's Halcyon System
News | Radiation Therapy | September 22, 2017
September 22, 2017 — Varian Medical Systems announced a patient at Penn Medicine, with head & neck cancer, became
BrainLAB Announces FDA Clearance For Two New Indication-Specific Radiosurgery Software Applications
Technology | Treatment Planning | September 21, 2017
Brainlab announced that it has received U.S. Food and Drug Administration (FDA) clearance for Elements Spine SRS and...
Accuray Showcases CyberKnife and Radixact Systems at ASTRO 2017
News | Radiation Therapy | September 21, 2017
Accuray Inc. announced that data and first-hand experience with its advanced CyberKnife and Radixact Systems will be...
RayCare Oncology Information System Being Shown at ASTRO 2017
News | Radiation Therapy | September 20, 2017
RaySearch will be exhibiting its next-generation oncology information system (OIS) RayCare, among other highlights, at...
ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients
News | Proton Therapy | September 20, 2017
ProCure Proton Therapy Center in Somerset, N.J., recently celebrated the five-year cancer-free milestone for the first...
Varian to Showcase Latest Radiation Therapy Technologies and Software at ASTRO 2017
News | Radiation Therapy | September 19, 2017
Varian Medical Systems announced it will be demonstrating its new Halcyon platform and HyperArc high-definition...
News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting
News | Radiation Therapy | September 19, 2017
September 19, 2017 — Elekta will highlight its Mosaiq Oncology...
News | Imaging | September 18, 2017
Mary Washington Hospital and Union Health-Union Hospital will both receive Safety FiRsT grants to implement safety...
Understanding True Patient-centered Care in Radiology
Sponsored Content | Whitepapers | Imaging | September 18, 2017
What is the true meaning of “patient-centered care”?
Overlay Init